NYSE$EW
Edwards Lifesciences Corp · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Reported financial results for the quarter ended March 31, 2023.
Edwards Lifesciences reported a strong start to 2023, exceeding expectations with Q1 sales growing 9% to $1.46 billion and adjusted EPS of $0.62. The company raised its full-year sales guidance and expects a return to higher sales growth, driven by its patient-focused innovation strategy.
- Q1 sales grew 9 percent to $1.46 billion; constant currency sales grew 13 percent.
- Q1 TAVR sales grew 8 percent; constant currency sales grew 11 percent.
- Q1 EPS of $0.56; adjusted EPS of $0.62.
- Raised full year 2023 sales guidance.
Headline financials
Revenue & EPS history
Edwards Lifesciences · Revenue · Quarterly
$1.46B
Revenue by segment
Edwards Lifesciences · $1.24B total across 3 segments · Q1 2023
- Transcatheter Aortic Valve Replacement$948M+7.6%76.6%
- Surgical Structural Heart$248M+12.4%20.1%
- Transcatheter Mitral & Tricuspid$41.6M+54.1%3.4%
Forward guidance
The company is raising its full year sales guidance for all product groups. Full year 2023 sales are expected to grow 10 to 12 percent. For the second quarter of 2023, the company projects total sales to be between $1.48 and $1.56 billion, and adjusted EPS of $0.62 to $0.68.
Tailwinds
- Full year 2023 sales are expected to grow 10 to 12 percent.
- TAVR sales of $3.8 to $4.0 billion.
- TMTT sales of $170 to $200 million.
- Critical Care sales of $870 to $940 million.
- Surgical Structural Heart sales at the high end of its $870 to $970 million range.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
-1.3%
Avg return
Earnings day
-2.1%
Avg return
5 days after
-1.5%
Avg return
30 days after
50%
35 / 70 earnings
Positive
+11.6%
Q1 2017
Best reaction
-31.4%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | +1.9% | +7.7% | |
| Q4 2025 | +3.0% | -1.5% | +6.2% | |
| Q3 2025 | -0.8% | -0.8% | +3.8% | |
| Q2 2025 | +0.1% | +4.1% | -0.8% | |
| Q1 2025 | +6.6% | +8.3% | +6.4% | |
| Q4 2024 | +6.9% | +7.4% | -2.3% | |
| Q3 2024 | -1.7% | -1.8% | -0.2% | |
| Q2 2024 | -31.4% | -26.8% | -18.6% | |
| Q1 2024 | -2.5% | -4.4% | -0.7% | |
| Q4 2023 | +0.6% | -1.2% | +9.0% | |
| Q3 2023 | -10.9% | -11.5% | -3.7% | |
| Q2 2023 | -9.8% | -10.5% | -16.9% | |
| Q1 2023 | -1.2% | -0.3% | -6.6% | |
| Q4 2022 | +7.1% | +8.0% | +5.5% | |
| Q3 2022 | -18.3% | -16.3% | -12.0% | |
| Q2 2022 | -4.8% | -3.2% | -13.6% | |
| Q1 2022 | -8.3% | -11.7% | -17.7% | |
| Q4 2021 | -6.9% | -0.3% | +3.2% | |
| Q3 2021 | -0.4% | -1.2% | -6.4% | |
| Q2 2021 | +2.0% | +4.2% | +5.8% | |
| Q1 2021 | +7.5% | +10.0% | +4.8% | |
| Q4 2020 | -3.7% | -5.3% | -4.0% | |
| Q3 2020 | -6.0% | -7.5% | +0.1% | |
| Q2 2020 | +0.3% | -0.6% | +1.0% | |
| Q1 2020 | +3.2% | -1.6% | +1.1% | |
| Q4 2019 | -5.5% | -2.7% | -12.0% | |
| Q3 2019 | +3.0% | +6.8% | +8.4% | |
| Q2 2019 | +10.8% | +9.7% | +11.7% | |
| Q1 2019 | -0.3% | -1.2% | -4.7% | |
| Q4 2018 | -0.0% | +0.8% | +2.9% | |
| Q3 2018 | -6.0% | -6.1% | -0.7% | |
| Q2 2018 | -8.5% | -8.2% | -8.6% | |
| Q1 2018 | -5.6% | -5.8% | +0.3% | |
| Q4 2017 | +4.1% | +0.4% | +6.3% | |
| Q3 2017 | -9.4% | -10.7% | -4.6% | |
| Q2 2017 | +0.4% | -0.6% | -3.5% | |
| Q1 2017 | +11.6% | +12.0% | +16.5% | |
| Q4 2016 | -6.8% | -6.6% | -3.9% | |
| Q3 2016 | -19.5% | -17.8% | -25.8% | |
| Q2 2016 | +7.4% | +7.5% | +7.7% | |
| Q1 2016 | +0.9% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +0.7% | — | — | |
| Q2 2015 | +0.7% | — | — | |
| Q1 2015 | -1.8% | — | — | |
| Q4 2014 | +7.5% | — | — | |
| Q3 2014 | +10.9% | — | — | |
| Q2 2014 | +9.4% | — | — | |
| Q1 2014 | +0.7% | — | — | |
| Q4 2013 | +1.0% | — | — | |
| Q3 2013 | -9.3% | — | — | |
| Q2 2013 | +2.3% | — | — | |
| Q1 2013 | -22.8% | — | — | |
| Q4 2012 | -7.1% | — | — | |
| Q3 2012 | -0.3% | — | — | |
| Q2 2012 | +4.5% | — | — | |
| Q4 2011 | -1.6% | — | — | |
| Q1 2012 | +11.6% | — | — | |
| Q3 2011 | -5.9% | — | — | |
| Q2 2011 | -3.5% | — | — | |
| Q4 2010 | +0.5% | — | — | |
| Q1 2010 | +0.5% | — | — | |
| Q1 2011 | -2.1% | — | — | |
| Q4 2008 | -1.7% | — | — | |
| Q1 2009 | -1.7% | — | — | |
| Q3 2010 | +1.3% | — | — | |
| Q3 2009 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro